Catching up to this column from May 15 by Mary Carmichael and Sharon Begley.
“How the road from promising scientific breakthrough to real-world remedy has become all but a dead end.”
“From 1996 to 1999, the U.S. food and Drug Administration approved 157 new drugs. In the comparable period a decade later–that is, from 2006 to 2009–the agency approved 74. Not among them were any cures, or even meaningfully effective treatments, for Alzheimer’s disease, lung or pancreatic cancer, Parkinson’s disease, Huntington’s disease, or a host of other afflictions that destroy lives.”
Read the entire column to get the authors’ take on what’s going on and what could be done about the dead end.